Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0051035 COMPOSITIONS AND METHODS OF CHIMERIC AUTOANTIBODY RECEPTOR T CELLS
The invention includes compositions comprising at least one chimeric autoantibody receptor (CAAR) specific for an autoantibody, vectors comprising the same,...
2017/0051034 Novel Glucagon Analogues
The present invention relates to novel peptide compounds which have a protracted profile of action and improved solubility and stability, to the use of the...
2017/0051033 Variants of C-Type Natriuretic Peptide
The present disclosure provides variants of C-type natriuretic peptide (CNP), pharmaceutical compositions comprising CNP variants, and methods of making CNP...
2017/0051032 ISLET AMYLOID POLYPEPTIDES WITH IMPROVED SOLUBILITY
The present disclosure provides for isolated non-naturally occurring, mutant-human IAPP polypeptides. These polypeptides can be formulated or co-formulated at...
2017/0051030 FUSION PROTEINS FOR TREATING CANCER AND RELATED METHODS
Aspects of the disclosure provide fusion proteins that bind cells expressing one or more target molecules including, for example, one or more cell surface...
2017/0051029 MOLECULES THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
This invention provides for a fusion protein between an IL2.alpha..beta..gamma. Selective Agonist protein (IL2 Selective Agonist) and a IgG Fc protein. The IL2...
2017/0051028 PROCESS FOR THE PURIFICATION OF A GROWTH FACTOR PROTEIN
A process of purifying a Growth Factor Protein in a purification sequence employing chromatography characterized in that at least one chromatography is...
2017/0051027 Keratin Nanomaterials and Methods of Production
The present disclosure relates to keratin nanomaterials, methods for obtaining keratin nanomaterials, and biomaterials made from keratin nanomaterials. In...
2017/0051026 Plasmodium falciparum antigens
The invention relates to antigens, associated with sterile immunity, and methods of their use, in an immunogenic formulation to confer an immune response...
2017/0051025 Silk Proteins
The present invention provides silk proteins, as well as nucleic acids encoding these proteins. The present invention also provides recombinant cells and/or...
2017/0051024 FILARIAL NEMATODE VACCINES, POLYPEPTIDES, AND NUCLEIC ACIDS
The present invention relates to vaccines comprising a ShK domain of a filarial nematode protein. These vaccines may be used for the prevention and/or...
2017/0051023 VACCINE
There is provided a NetB epitope polypeptide comprising at least 10 contiguous amino acids from SEQ ID NO:1 and comprising a mutation in at least one position...
2017/0051022 ADENOVIRUS COMPRISING AN ALBUMIN-BINDING MOIETY
The invention relates to a recombinant adenovirus comprising an albumin-binding moiety on the outer surface of the adenoviral hexon protein, pharmaceutical...
2017/0051021 PEPTIDE AGONISTS OF TOLL-LIKE RECEPTOR 5 LIGAND AND METHOD OF USE
The present invention refers to peptides functionally related to Toll-like receptor 5 (TLR-5) ligand, having a sequence of amino acids ordered by means of the...
2017/0051020 MODULAR DNA-BINDING DOMAINS AND METHODS OF USE
The present invention refers to methods for selectively recognizing a base pair in a DNA sequence by a polypeptide, to modified polypeptides which specifically...
2017/0051019 THERAPEUTIC HPV18 VACCINES
Provided is designer nucleic acid constructs and polypeptides that can be used as therapeutic vaccines against HPV18 and/or HPV16.
2017/0051018 INTEGRIN-BLOCKING POLYPEPTIDES AND USES THEREOF
A series of integrin blockers that present strong angiogenesis inhibiting performance, high integrin affinity and integrin-bonding capacity is provided. This...
2017/0051017 PEPTIDOMIMETICS POSSESSING PHOTO-CONTROLLED BIOLOGICAL ACTIVITY
The present invention relates to pharmaceutically and/or diagnostically active compounds, in particular peptide analogues (peptidomimetics), which can be...
2017/0051016 ANTI-INFLAMMATORY NANOFIBERS
Provided herein are anti-inflammatory nanofibers and methods of use thereof. In particular methods are provided for the use of anti-inflammatory nanofibers in...
2017/0051015 METHODS OF DEVELOPING SELECTIVE PEPTIDE ANTAGONISTS
Methods and compositions related to the selective, specific disruption of multiple ligand-receptor signaling interactions, such as ligand-receptor interactions...
2017/0051014 PEPTIDE HAVING EFFICACY FOR REMEDYING HYPOPIGMENTATION AND INHIBITING ADIPOGENESIS, AND USE OF SAME
A peptide formed from the amino acid sequence of SEQ ID NO: 1 or SEQ ID NO: 2, according to the present invention, shows a melanogenesis increment activity and...
2017/0051013 HEPCIDIN MIMETIC PEPTIDES AND USES THEREOF
Compounds and methods are described herein that can be used to treat subjects for conditions related to hepcidin activity, such as but not limited diseases of...
2017/0051012 INHIBITORS OF NF KAPPA-B ACTIVITY FOR TREATMENT OF DISEASES AND DISORDERS
Peptides and methods of use thereof, are disclosed for use in treating various disease and disorders, including inflammation, pain, oral mucositis, oral...
2017/0051011 METHODS OF PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVES
The invention relates to novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.
2017/0051010 CHROMATOGRAPHY METHOD
The present invention relates to a method for removal of large contaminants, such as virus, in a chromatographic process for purification of a target molecule,...
2017/0051009 PROCESS FOR ABIRATERONE ACETATE
The present invention provides a novel process for the preparation of abiraterone. The present invention also provides a novel process for the preparation of...
2017/0051008 ANDROSTANE AND PREGNANE STEROIDS WITH POTENT ALLOSTERIC GABA RECEPTOR CHLORIDE IONOPHORE MODULATING PROPERTIES
This invention describes compounds of Structures 1, 2, and 3 and their use as allosteric modulators of the GABA receptor chloride ionophore complex to...
2017/0051007 PHARMACEUTICAL COMPOSITIONS AND METHODS
This invention relates the use of cortisol blockers (e.g., glucocorticoid receptor [GR] antagonists) for the treating or preventing viral infections, treating...
2017/0051006 SHIP INHIBITORS AND USES THEREOF
The present invention relates to SHIP inhibitor compounds and methods for using these compounds. In particular, the present invention discloses the following...
2017/0051005 Primers and Methods for Nucleic Acid Amplification
A primer and method for amplification of a target nucleic acid, the primer adapted to conform into a conformation that dissociates from a complementary strand...
2017/0051004 SOFOSBUVIR IN CRYSTALLINE FORM AND PROCESS FOR ITS PREPARATION
Sofosbuvir in crystalline Form .alpha., process for its production and use in pharmaceutical compositions.
2017/0051003 REAGENT-CONTROLLED STEREOSELECTIVE GLYCOSYLATION
Provided are methods for the efficient stereoselective formation of glycosidic bonds, without recourse to prosthetic or directing groups.
2017/0051002 Rebaudioside A Crystal And Its Preparation Method And Use
Disclosed is a rebaudioside A crystal form 7, of which the structure is represented by the Formula I. The X-ray powder diffraction (XRPD) pattern of the...
2017/0051001 PURIFICATION OF EPIDAUNORUBICIN
A method for purifying epidaunorubicin is provided. The purification method involves the removal of the impurity epi-feudomycin, which is formed as a...
2017/0051000 C-TERMINAL HSP90 INHIBITORS
Hsp90 C-terminal inhibitors and pharmaceutical compositions containing such compounds are provided. The compounds of the disclosure are useful for the...
2017/0050999 GERMANIUM- AND ZIRCONIUM-CONTAINING COMPOSITION FOR VAPOR DEPOSITION OF ZIRCONIUM-CONTAINING FILMS
Disclosed are Germanium- and Zirconium-containing precursors having one of the following formulae: ##STR00001## wherein each R.sup.1, R.sup.2, R.sup.3, R.sup.4,...
2017/0050998 COBALT COMPOUND, THIN FILM-FORMING RAW MATERIAL, AND METHOD FOR PRODUCING THIN FILM
The cobalt compound of this invention is represented by general formula (I) below. In general formula (I), R.sup.1 to R.sup.3 independently represent a...
2017/0050997 HETERODINUCLEAR PLATINUM-RUTHENIUM COMPLEXES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
A novel class of heterodinuclear Pt--Ru complexes are provided, and the methods for preparing the complexes are described. The inhibitory activities of the...
2017/0050996 ANTIOXIDANT COMPOUNDS AND THEIR USE
Disclosed herein are novel amine-functionalized porphyrin compounds, as wells as pharmaceutically acceptable salts or esters thereof. The disclosed compounds...
2017/0050995 Chromium Metal Organic Frameworks and Synthesis of Metal Organic Frameworks
The present invention relates to monocrystalline metal organic frameworks comprising chromium ions and carboxylate ligands and the use of the same, for example...
2017/0050994 N-Heterocyclic Carbene Complexes Of Metal Imido Alkylidenes And Metal OXO Alkylidenes, And The Use Of Same
The invention relates to an N-heterocyclic carbene complex of general formulas I to IV (I) (II) (III) (IV), according to which A1 stands for NR2 or PR2, A2...
2017/0050993 Substituted 4-Phenyl Pyridines
Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the neurokinin...
2017/0050992 NOVEL ANNELATED PHENOXYACETAMIDES
The present invention relates to compounds of formula (I) ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, and Z.sup.- have one of the meanings as indicated in...
2017/0050991 SUBSTITUTED ANGULAR BISTETRACENES AND SUBSTITUTED ANGULAR BISOLIGOACENES AND ELECTRONIC DEVICES MADE WITH SAME
We report the synthesis and characterization of novel bistetracenes, an unconventional, linearly extended conjugated core with eight fused rings. Also...
2017/0050990 METHODS AND COMPOSITIONS FOR PREPARING SILICA AEROGELS
Cross-linked sol-gel like materials and cross-linked aerogels, as well as methods for making such cross-linked sol-gel like materials and cross-linked aerogels...
2017/0050989 Molecular Imaging Probes
This disclosure relates to compounds of formula (I) shown below: [formula (I)], or a pharmaceutically acceptable salt thereof. These compounds can be used as...
2017/0050988 DOTAM DERIVATIVES FOR THERAPEUTIC USE
A compound of formula (I), a stereoisomeric form thereof, or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined herein, is...
2017/0050987 PYRIMIDINONES AS PI3K INHIBITORS
The present invention provides pyrimidinones that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases...
2017/0050986 METHODS OF PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVES
The invention relates to novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.
2017/0050985 METHODS OF PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVES
The invention relates to novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.